Class / Patent application number | Description | Number of patent applications / Date published |
514650000 | The aryl ring or aryl ring system is bonded directly to another ring or ring system | 10 |
20090005456 | PHENYL SUBSTITUTED CYCLOALKYLAMINES AS MONOAMINE REUPTAKE INHIBITORS - Phenyl-substituted cyclohexylamine derivatives and method for their synthesis and characterization are disclosed. Use of these compounds to treat/prevent neurological disorders as well as methods for their synthesis are set forth herein. Exemplary compounds of the invention inhibit reuptake of endogenous monoamines, such as dopamine, serotonin and norepinephrine (e.g., from the synaptic cleft) and modulate one or more monoamine transporter. Pharmaceutical formulations incorporating compounds of the invention are also provided. | 01-01-2009 |
20090076163 | DEUTERIUM-ENRICHED DAPOXETINE - The present application describes deuterium-enriched dapoxetine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 03-19-2009 |
20100004341 | C-(2-Phenyl-Cyclohexyl)-Methylamine Compounds for Therapy of Fibromyalgia - Pharmaceutical formulations of [2-(3-methoxyphenyl)-cyclohexylmethyl]-dimethylamine and the metabolites thereof suitable for treating fibromyalgia or chronic pain due to fibromyalgia, and related methods of treating fibromyalgia or chronic pain due to fibromyalgia are described. | 01-07-2010 |
20100331424 | Use of Axomadol for Treatment of Arthrosis Pain - The use of axomadol for the treatment of pain in arthrosis. | 12-30-2010 |
20110201690 | DEUTERIUM-ENRICHED DAPOXETINE - The present application describes deuterium-enriched dapoxetine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 08-18-2011 |
20110301244 | FAST ACTING NARATRIPTAN COMPOSITION - The present invention relates to pharmaceutical compositions containing Naratriptan, a compound selected from the group consisting of 2-HPOD, 2-HPHM, 4-PPED, 4-BPED and 2-PPED, and optionally, a pharmaceutically acceptable excipient. | 12-08-2011 |
20150038590 | N-CYCLOALKYL-N-[(CYCLOALKENYLPHENYL)METHYLENE]-(THIO)CARBOXAMIDE DERIVATIVES - The present invention relates to fungicidal N-cycloalkyl-N-[(cycloalkenylphenyl)methylene]carboxamide derivatives and their thiocarbonyl derivatives, their process of preparation and intermediate compounds for their preparation, their use as fungicides, particularly in the form of fungicidal compositions and methods for the control of phytopathogenic fungi of plants using these compounds or their compositions. | 02-05-2015 |
20150297538 | Intravenous Administration of Tramadol - A method of treating pain, e.g., acute post-operative pain, by administering to a human patient(s) a therapeutically effective dose of tramadol intravenously over a prolonged time period is disclosed. In certain embodiments, the dose is intravenously administered in a time period from about 10 minutes to about 3 hours, preferably from about 10 minutes to about 30 minutes. In other embodiments, intravenous doses are administered at suitable time intervals over a time period from about 3 hours to 48 hours. | 10-22-2015 |
20150342908 | SECOAPORPHINE ALKALOID DERIVATIVE FOR ACTIVATING AMP-DEPENDENT PROTEIN KINASE - The present invention provides a method for activating the AMP-dependent protein kinase (AMPK) in a subject comprising administering the subject with a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound having the general Formula I, preferably 1,10-dihydroxyaporphine. The pharmaceutical composition is able to activate AMPK, and thus is effective in the regulation of cell growth and metabolism, and the treatment of AMPK associated diseases. | 12-03-2015 |
20160150777 | N-CYCLOALKYL-N-[(BICYCLYLPHENYL)METHYLENE]-(THIO)CARBOXAMIDE DERIVATIVES | 06-02-2016 |